eGFR calculated from cystatin C: implications for dosing of direct oral anticoagulants.
作者信息
Shin Jung-Im, Ballew Shoshana, Bosi Alessandro, Hjemdahl Paul, Grams Morgan E, Coresh Josef, Inker Lesley A, Carrero Juan-Jesus
机构信息
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
出版信息
Nephrol Dial Transplant. 2024 Nov 27;39(12):2117-2119. doi: 10.1093/ndt/gfae171.
Abstract
摘要
相似文献
1
eGFR calculated from cystatin C: implications for dosing of direct oral anticoagulants.根据胱抑素C计算的估算肾小球滤过率：对直接口服抗凝剂给药的影响
Nephrol Dial Transplant. 2024 Nov 27;39(12):2117-2119. doi: 10.1093/ndt/gfae171.
2
Creatinine Versus Cystatin C: Differing Estimates of Renal Function in Hospitalized Veterans Receiving Anticoagulants.肌氨酸酐与胱抑素 C：接受抗凝剂治疗的住院退伍军人的肾功能估计值不同。
J Gen Intern Med. 2018 Aug;33(8):1299-1306. doi: 10.1007/s11606-018-4461-3. Epub 2018 May 31.
3
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.估算肾小球滤过率、白蛋白尿与不良结局：一项个体参与者数据的荟萃分析。
JAMA. 2023 Oct 3;330(13):1266-1277. doi: 10.1001/jama.2023.17002.
4
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.直接口服抗凝剂与华法林在预防慢性肾脏病房颤患者中风和全身性栓塞事件方面的比较
Cochrane Database Syst Rev. 2017 Nov 6;11(11):CD011373. doi: 10.1002/14651858.CD011373.pub2.
5
Evaluation of race-free eGFR equations in individuals of different ethnicity.不同种族个体中无种族因素的估算肾小球滤过率（eGFR）方程的评估。
Blood Press. 2025 Dec;34(1):2533456. doi: 10.1080/08037051.2025.2533456. Epub 2025 Jul 22.
6
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial.慢性肾脏病与替尔泊肽对射血分数保留的肥胖心力衰竭患者的影响：SUMMIT试验
J Am Coll Cardiol. 2025 May 13;85(18):1721-1735. doi: 10.1016/j.jacc.2025.03.009. Epub 2025 Mar 31.
7
Renal elimination and eGFR prediction of proenkephalin.前脑啡肽原的肾脏清除及估算肾小球滤过率预测
Scand J Clin Lab Invest. 2025;85(4):281-286. doi: 10.1080/00365513.2025.2512383. Epub 2025 Jun 10.
8
Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment.胱抑素 C 和肌酐作为口服抗凝治疗期间出血并发症、心血管事件和死亡的标志物。
Thromb Res. 2013 Aug;132(2):e77-82. doi: 10.1016/j.thromres.2013.06.011. Epub 2013 Jul 5.
9
Population pharmacokinetics of penicillin G: insights into increased clearance at low concentrations to guide development of improved long-acting formulations for syphilis and prevention of rheumatic fever.青霉素G的群体药代动力学：低浓度时清除率增加的见解，以指导改进长效梅毒制剂的研发及预防风湿热。
Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0026925. doi: 10.1128/aac.00269-25. Epub 2025 May 20.
10
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism.口服直接凝血酶抑制剂或口服Xa因子抑制剂用于治疗肺栓塞。
Cochrane Database Syst Rev. 2015 Dec 4;2015(12):CD010957. doi: 10.1002/14651858.CD010957.pub2.
本文引用的文献
1
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
2
Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.非维生素 K 拮抗剂口服抗凝剂（NOACs）在房颤患者中不适当剂量的结果和驱动因素：系统评价和荟萃分析。
Heart. 2023 Jan 11;109(3):178-185. doi: 10.1136/heartjnl-2022-321114.
3
The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care.斯德哥尔摩 CREAtinine 测量（SCREAM）项目：促进慢性肾脏病护理的改善。
J Intern Med. 2022 Mar;291(3):254-268. doi: 10.1111/joim.13418. Epub 2022 Jan 13.
4
Different glomerular filtration rate estimating formula for prescribing DOACs in oldest patients: appropriate dosage and bleeding risk. Post hoc analysis of a prospective cohort.不同肾小球滤过率估算公式在高龄患者中应用 DOACs 的比较：合适的剂量和出血风险。一项前瞻性队列的事后分析。
Aging Clin Exp Res. 2022 Mar;34(3):591-598. doi: 10.1007/s40520-021-01986-w. Epub 2021 Oct 18.
5
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程，无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
6
Comparing GFR Estimating Equations Using Cystatin C and Creatinine in Elderly Individuals.比较老年个体中使用胱抑素C和肌酐的肾小球滤过率估算方程
J Am Soc Nephrol. 2015 Aug;26(8):1982-9. doi: 10.1681/ASN.2014060607. Epub 2014 Dec 19.
Zotero 插件